The American Society of Clinical Oncology, Association for Molecular Pathology, College of American Pathologists and American Society of Clinical Pathology have released new guidelines for molecular testing in cases of primary or metastatic colorectal carcinoma, according to a Medscape report.
The new guidelines are designed to establish standard molecular marker testing and targeted therapies for patients with primary or metastatic colorectal carcinoma.
The guidelines are open to public comment through April 22.
Click here to read the full set of guidelines.
More articles on gastroenterology:
Dr. Christopher Meyer named CEO of Holzer Health System
Squaring off in GI: Employment vs. private practice
5 most read GI articles – March 30 to April 3
AdventHealth Tampa (Fla.) has opened a Center for Interventional Endoscopy, the only interventional endoscopy center in the Tampa Bay region. …
From pay shifts to projected increases in colorectal cancer cases, here are 13 numbers worrying gastroenterologists: 3%. How much gastroenterologist…
As gastroenterology practices adapt to an evolving healthcare landscape, several major deals and partnerships are reshaping the field. Here are…
Comments are closed.